Yasuhisa Fujii

63PUBLICATIONS
90CO-AUTHORS
Predictive and prognostic markersNanotoxicology, health and safetyGene and molecular therapyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (63)

|Sep 14, 2026
Distinct Predictors of Early Postoperative and Long-Term Renal Function Decline Following Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma.

|Aug 28, 2026
Efficacy of Vibegron in Overactive Bladder: A Bayesian Cross-Trial Synthesis of Benefit Probabilities and Decision Thresholds.

|Aug 06, 2026
Real-World Outcomes of Olaparib Treatment in Japanese Patients With Metastatic Castration-Resistant Prostate Cancer Harboring BRCA Pathogenic or Likely Pathogenic Variants.

|Jul 22, 2026
Probabilistic Multicriteria Decision Analysis of Minimally Invasive Treatments for Benign Prostatic Obstruction: A Secondary Analysis of Network Meta-Analysis Data.

|May 12, 2026
Performance of Prognostic Models in Patients With Metastatic Urothelial Carcinoma Treated With Enfortumab Vedotin After Platinum-Based Chemotherapy and Immune Checkpoint Inhibitors: YUSHIMA Study.

|Feb 16, 2026
Androgen Receptor Signaling Inhibitors for Metastatic Hormone Sensitive Prostate Cancer in Asians: Indirect Comparison.

Wei Chen, Soichiro Yoshida, Yasuhisa Fujii

Pageof 11

Frequent Collaborators

37 joint publications

Hajime Tanaka

26 joint publications

Soichiro Yoshida

16 joint publications

Yuma Waseda

15 joint publications

Motohiro Fujiwara